Use of GnRH agonists to support the luteal phase during infertility treatment
US7671027B2 · kind B2 · utility
58Cited by
2References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 29, 2003 |
| Grant date | Mar 2, 2010 |
| Priority date | — |
| Expiry date | Jan 14, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns the use of an agonist of an hypothalamic hormone for the preparation of a pharmaceutical agent to support the luteal phase during infertility treatment of female mammals and more specifically of woman. According to this invention, the pharmaceutical agent is suitable to be used for supporting the luteal phase after a spontaneous ovulation or after stimulation of follicular growth, trigger of final follicular maturation and ovulation with one or several additional agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.